Clinical Trial Update: Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pharmacokinetics of 122-0551 and its effects on adrenal suppression in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• 122-0551

Snippet

Sponsor: Therapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-26